Page 70 - GTM-2-3
P. 70
Global Translational Medicine Influence of ferroptosis in neurological diseases
transcription factors during the pathogenesis of these two homeostasis and oxidative stress: An intimate relationship.
neurodegenerative diseases. Thus, this study identifies Biochim Biophys Acta Mol Cell Res, 1866: 118535.
potential ferroptosis markers that may play a driving role https://doi.org/10.1016/j.bbamcr.2019.118535
in these diseases. Finally, we have devised therapeutic
measures that can be experimentally tested for their 3. Reichert CO, de Freitas FA, Sampaio-Silva J, et al., 2020,
Ferroptosis mechanisms involved in neurodegenerative
efficacy in combating ferroptosis in AD and PD. This study diseases. Int J Mol Sci, 21: 8765.
provides valuable insights for experimental biologists to
use these ferroptosis markers and demystify their mode of https://doi.org/10.3390/ijms21228765
action in causing neurodegeneration, thereby advancing 4. Xu Y, Zhao J, Zhao Y, et al., 2023, The role of ferroptosis in
our understanding of these diseases. neurodegenerative diseases. Mol Biol Rep, 50: 1655–1661.
Acknowledgments https://doi.org/10.1007/s11033-022-08048-y
5. Chen X, Yu C, Kang R, et al., 2020, Iron metabolism in
This research is an outcome of the autonomous research ferroptosis. Front Cell Dev Biol, 8: 590226.
group “Ethophilia.” We thank all the members for their
constant support and enthusiasm. https://doi.org/10.3389/fcell.2020.590226
6. Munshi C, Bhattacharya S, 2022, The “irony” of ferroptosis:
Funding A review on neurological challenges. In: Xu K, editor. Cell
This research did not receive any specific grant from Death and Disease. Rijeka: IntechOpen.
funding agencies in the public, commercial, or not-for- https://doi.org/10.5772/intechopen.108737
profit sectors. 7. Ou M, Jiang Y, Ji Y, et al., 2022, Role and mechanism of
ferroptosis in neurological diseases. Mol Metab, 61: 101502.
Conflict of interest
https://doi.org/10.1016/j.molmet.2022.101502
The authors declare no conflict of interest with any
organization or financial entity. 8. Yan H, Zou T, Tuo Q, et al., 2021, Ferroptosis: Mechanisms
and links with diseases. Signal Transduct Target Ther, 6: 49.
Author contributions https://doi.org/10.1038/s41392-020-00428-9
Conceptualization: Deepyaman Das, Chayan Munshi 9. Ma H, Dong Y, Chu Y, et al., 2022, The mechanisms of
Formal analysis: Deepyaman Das ferroptosis and its role in Alzheimer’s disease. Front Mol
Investigation: Deepyaman Das, Chayan Munshi Biosci, 9: 965064.
Methodology: Deepyaman Das https://doi.org/10.3389/fmolb.2022.965064
Writing – original draft: Deepyaman Das, Kalpesh Jas, 10. Ward RJ, Zucca FA, Duyn JH, et al., 2014, The role of iron
Sourish Pramanik in brain ageing and neurodegenerative disorders. Lancet
Writing – review & editing: Deepyaman Das, Chayan Neurol, 13: 1045–1060.
Munshi
https://doi.org/10.1016/S1474-4422(14)70117-6
Ethics approval and consent to participate 11. Zhang Y, Wang M, Chang W, 2022, Iron dyshomeostasis and
Not applicable. ferroptosis in Alzheimer’s disease: Molecular mechanisms of
cell death and novel therapeutic drugs and targets for AD.
Consent for publication Front Pharmacol, 13: 983623.
Not applicable. https://doi.org/10.3389/fphar.2022.983623
12. Yang WS, Kim KJ, Gaschler MM, et al., 2016, Peroxidation
Availability of data of polyunsaturated fatty acids by lipoxygenases drives
All the data used in the study are publicly available. ferroptosis. Proc Natl Acad Sci U S A, 113: E4966–E4975.
https://doi.org/10.1073/pnas.1603244113
References
13. Chen K, Jiang X, Wu M, et al., 2021, Ferroptosis, a potential
1. Sun Y, Chen P, Zhai B, et al., 2020, The emerging role therapeutic target in Alzheimer’s disease. Front Cell Dev
of ferroptosis in inflammation. Biomed Pharmacother, Biol, 9: 704298.
127: 110108. https://doi.org/10.3389/fcell.2021.704298
https://doi.org/10.1016/j.biopha.2020.110108
14. Chen JJ, Thiyagarajah M, Song J, et al., 2022, Lanctôt, altered
2. Galaris D, Barbouti A, Pantopoulos K, 2019, Iron central and blood glutathione in Alzheimer’s disease and
Volume 2 Issue 3 (2023) 11 https://doi.org/10.36922/gtm.0318

